Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed250%
unknown125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions

NCT06021080
unknownnot_applicable

ADVOS® Versus CVVHD in Metabolic or Mixed Acidosis

NCT05842369
completednot_applicable

Cytokine Removal With CVVHD Compared to CVVH

NCT04048525
completednot_applicable

Impact of CVVHD With Adsorption Capacity Membranes in Septic Acute Kidney Injury

NCT01790620

Clinical Trials (4)

Showing 4 of 4 trials
NCT06021080

Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions

Recruiting
NCT05842369Not Applicable

ADVOS® Versus CVVHD in Metabolic or Mixed Acidosis

Unknown
NCT04048525Not Applicable

Cytokine Removal With CVVHD Compared to CVVH

Completed
NCT01790620Not Applicable

Impact of CVVHD With Adsorption Capacity Membranes in Septic Acute Kidney Injury

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4